Processa Pharmaceuticals (PCSA) PT Raised to $22 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Francois Brisebois raised the price target on Processa Pharmaceuticals (NASDAQ: PCSA) to $22.00 (from $20.00) while maintaining an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
